Daxor Revenue Growth Rates (DXR), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Daxor Corporation  (DXR)
 

DXR's Revenue Growth by Quarter and Year

Daxor's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DXR Revenue (in millions $) FY 2011 FY 2010 FY 2009 FY 2008
4th Quarter December 0.00
3rd Quarter September 0.34
2nd Quarter June 0.36
1st Quarter March 0.45
FY 1.15





DXR Revenue fourth quarter 2011 Y/Y Growth Comment
Daxor Corporation in the fourth quarter 2011 recorded of $ 0.00 millions.

According to the results reported in the fourth quarter 2011, Daxor Corporation achieved the best Revenue growth in Medical Equipment & Supplies industry. While Daxor Corporation' s Revenue meltdown of -100% ranks overall at the positon no. in the fourth quarter 2011.


DXR Revenue ( Y/Y Growth %) 2011
 2010 2009 2008
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   210.81 % - - -

Financial Statements
Daxor's fourth quarter 2011 Revenue $ 0.00 millions DXR's Income Statement
Daxor's fourth quarter 2010 Revenue $ 0.37 millions Quarterly DXR's Income Statement


DXR Revenue (Quarter on Quarter Growth %)

 2011
 2010 2009 2008
4th Quarter December - - - -
3rd Quarter September -5.56 % - - -
2nd Quarter June -20 % - - -
1st Quarter March 21.62 % - - -
FY (Year on Year)   210.81 % - - -


Back to DXR Growth rate Comparisons >> Back to DXR Growth rate Comparisons >>


Revenue fourth quarter 2011 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue fourth quarter 2011 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2008, 2009, 2010, 2011

Daxor's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


DXR's IV. Quarter Q/Q Revenue Comment
Recent accomplishment of 0.00 millions by Daxor Corporation come out even worse considering the 0.34 millions a quarter before.

Within Medical Equipment & Supplies industry Daxor Corporation achieved highest sequential Revenue growth. While Daxor's Revenue growth quarter on quarter, overall rank is .


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


DXR's IV. Quarter Q/Q Revenue Comment
Recent accomplishment of 0.00 millions by Daxor Corporation come out even worse considering the 0.34 millions a quarter before.

Within Medical Equipment & Supplies industry Daxor Corporation achieved highest sequential Revenue growth. While Daxor's Revenue growth quarter on quarter, overall rank is .


Daxor's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2011)		 12 Months Ending
 12 Months Ending
 12 Months Ending
 12 Months Ending
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
In the Dec 31 2011 period, Daxor's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Daxor Corporation achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Dec 31 2011 period, Daxor's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Daxor Corporation achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
DXR's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue meltdown for the quarter ending Dec 31 2011 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2011
Eli Lilly And Company-2.27%$ -2.269 millions
Tenet Healthcare Corp-3.26%$ -3.259 millions
Alnylam Pharmaceuticals Inc -3.48%$ -3.478 millions
Magellan Health inc -3.70%$ -3.703 millions
Escalon Medical Corp -4.32%$ -4.319 millions
Pfizer Inc-4.64%$ -4.641 millions
Surmodics Inc -4.84%$ -4.839 millions
Allied Healthcare Products inc -6.33%$ -6.326 millions
Inotiv Inc -7.10%$ -7.095 millions
Lannett Company Inc-7.67%$ -7.674 millions
Boston Scientific Corporation-7.69%$ -7.692 millions
Regeneron Pharmaceuticals Inc -8.00%$ -8.003 millions
Wright Medical Group N v -8.25%$ -8.255 millions
Aeon Global Health Corp.-8.58%$ -8.575 millions
Sunlink Health Systems Inc -8.64%$ -8.641 millions
Shengtai Pharmaceutical, Inc.-12.46%$ -12.461 millions
Amag Pharmaceuticals inc -13.43%$ -13.432 millions
Invacare Holdings Corporation-17.13%$ -17.130 millions
Orthofix Medical Inc -17.49%$ -17.495 millions
Procyon Corporation-18.01%$ -18.006 millions
Thermogenesis Holdings Inc -18.52%$ -18.515 millions
Imaging Diagnostic Systems Inc-19.12%$ -19.118 millions
Ani Pharmaceuticals Inc-20.02%$ -20.019 millions
Pro dex Inc -20.30%$ -20.302 millions
Astrotech Corp-20.79%$ -20.793 millions
Wearable Health Solutions, Inc.-25.45%$ -25.449 millions
Scientific Industries Inc -41.05%$ -41.048 millions
Dyne Therapeutics Inc -47.23%$ -47.228 millions
Momenta Pharmaceuticals inc -49.50%$ -49.499 millions
Elite Pharmaceuticals Inc -58.42%$ -58.417 millions


About Daxor Revenue Growth Rates (DXR), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.